Status:
COMPLETED
The Relationship Between Serum Endocan and ADMA Levels and Penile Doppler Ultrasonography in Erectile Dysfunction
Lead Sponsor:
Ankara Etlik City Hospital
Conditions:
Evaluation of the Relationship Between Serum Biomarkers (Endocan and ADMA) and Penile Doppler Ultrasonography Findings of Patients With Severe Erectile Dysf
Eligibility:
MALE
50-70 years
Brief Summary
The gold standard diagnosis in patients admitted to the hospital with the complaint of erectile dysfunction is penile doppler ultrasonography. This procedure is an invasive procedure and can cause var...
Eligibility Criteria
Inclusion
- Patients with severe erectile dysfunction according to International Index of Erectile Function-15 questionnaire
- Patients who have not received medical or surgical treatment before
- Patients without comorbidity and related drug use
Exclusion
- Patients who have had previous pelvic trauma or surgery,
- Patients who have benefited from using phosphodiesterase-5 enzyme inhibitors,
- Patients with psychogenic erectile dysfunction and moderate or mild erectile dysfunction according to International Index of Erectile Function-15 questionnaire,
- Patients who have neurological disease, chronic liver disease and patients with chronic renal failure and those who used drugs that could cause erectile dysfunction
Key Trial Info
Start Date :
April 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 12 2020
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT05979467
Start Date
April 17 2017
End Date
June 12 2020
Last Update
August 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara City Hospital Bilkent
Ankara, Turkey (Türkiye), 06800